Citation Impact
Citing Papers
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: Prospective randomized controlled trial
2006
Development and validation of the Nancy histological index for UC
2015 Standout
Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn’s disease
1998
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon
2017 Standout
Reductions in 28-Day Mortality Following Hospital Admission for Upper Gastrointestinal Hemorrhage
2011 Standout
Cytokines in inflammatory bowel disease
2014 Standout
Systemic and topical steroids in inflammatory bowel disease
2004
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Ulcerative Colitis
2011 Standout
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
A randomised placebo controlled trial of pegylated interferon α in active ulcerative colitis
2003
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Sunlight and Vitamin D
2013 Standout
Suppression of inflammation in ulcerative colitis by interferon-β-1a is accompanied by inhibition of IL-13 production
2010
Cochrane reviews of educational and self-management interventions to guide nursing practice: A review
2008 Standout
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease
2011 Standout
Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomised trial
2003
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Crohn's disease
2012 Standout
Second‐look endoscopy with thermal coagulation or injections for peptic ulcer bleeding: A meta‐analysis
2009
Epidemiology and risk factors for IBD
2015 Standout
Systematic Review of the Predictors of Recurrent Hemorrhage After Endoscopic Hemostatic Therapy for Bleeding Peptic Ulcers
2008
New therapies for inflammatory bowel disease: from the bench to the bedside
2011
The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota
2002 Standout
A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
2000 Standout
Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategies
2003
Ulcerative colitis
2012 Standout
Outcome of endoscopic treatment for peptic ulcer bleeding: Is a second look necessary? A meta-analysis
2003
Recent advances in the endoscopic diagnosis and therapy of upper gastrointestinal, small intestinal, and colonic bleeding
2002
Crohn's disease
2016 Standout
New pathophysiological insights and modern treatment of IBD
2010
European evidence-based Consensus on the management of ulcerative colitis: Special situations
2008
Medical therapy for ulcerative colitis 2004
2004
Management of Patients With Ulcer Bleeding
2012 Standout
Ulcerative colitis
2016 Standout
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations
2012
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
2006 Standout
Immunomodulatory functions of type I interferons
2012
Ulcerative colitis
2020 Standout
Interferon-β-1a for the Treatment of Steroid-Refractory Ulcerative Colitis: A Randomized, Double-Blind, Placebo-Controlled Trial
2005
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Systematic review: the effectiveness of budesonide therapy for Crohn's disease
2002
Interferon β-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study
2003
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
2011
Management of Crohn's Disease in Adults
2009 Standout
Routine Second-Look Endoscopy: Ineffective, Costly, and Potentially Misleading
2004
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
State of the Art: Ibd Therapy and Clinical Trials in Ibd
2005
The limitations of corticosteroid therapy in Crohn’s disease
2001
Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
2006 Standout
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
2007
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Psychological interventions for treatment of inflammatory bowel disease
2011
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections
2014 StandoutNobel
Budesonide versus prednisone in the treatment of active Crohn's disease
1998
Management of stress in inflammatory bowel disease: a therapeutic option?
2009
The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases
2013
Long-Term Evolution of Disease Behavior of Crohn's Disease
2002 Standout
A randomized placebo-controlled trial of pegylated interferon alpha in active ulcerative colitis
2003
Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding
2003
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Budesonide for induction of remission in Crohn's disease
2015
Works of T. Andus being referenced
Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group.
1996
Effect of Programmed Endoscopic Follow-up Examinations on the Rebleeding Rate of Gastric or Duodenal Peptic Ulcers Treated by Injection Therapy: A Prospective, Randomized Controlled Trial
1998
Patient Education in Inflammatory Bowel Disease does not Influence Patients Knowledge and Long-Term Psychosocial Well-Being
2005
Successful Treatment of Steroid Refractory Active Ulcerative Colitis with Natural Interferon-β - an Open Long-Term Trial
2007
Induction and maintenance of clinical remission by interferon‐β in patients with steroid‐refractory active ulcerative colitis—an open long‐term pilot trial
2002